Document Detail


The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.
MedLine Citation:
PMID:  21175646     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The efficacy of granulocyte transfusions in patients with HLA alloimmunization is uncertain. A flow cytometric assay using dihydrorhodamine 123 (DHR), a marker for cellular NADPH oxidase activity, was used to monitor the differential survival of transfused oxidase-positive granulocytes in alloimmunized patients with chronic granulomatous disease (CGD).
STUDY DESIGN AND METHODS: Ten patients with CGD and serious infections were treated with daily granulocyte transfusions derived from steroid and granulocyte-colony-stimulating factor-stimulated donors. The proportion of neutrophils with intact oxidase activity was quantitated by DHR fluorescence on samples drawn before and 1 hour after transfusion. The incidence of acute transfusion reactions was correlated with the results of DHR fluorescence and biweekly HLA serologic screening assays.
RESULTS: Eight of 10 patients experienced acute adverse reactions in association with granulocyte transfusions. Four had only chills and/or fever, and four experienced respiratory compromise; all eight exhibited HLA alloimmunization. Mean (± SD) oxidase-positive cell recovery was 19.7 ± 17.4% (n = 15 transfusions) versus 0.95 ± 1.59% (n = 16) in the absence and presence of HLA allosensitization, respectively (p < 0.01). Greater than 1% in vivo recovery of DHR-enhancing donor granulocytes was strongly correlated with lack of HLA alloimmunization.
CONCLUSION: The ability to detect DHR-positive donor granulocytes by flow cytometry is strongly correlated with absence of HLA alloimmunization and lack of acute reactions to granulocyte transfusions in patients with CGD. If HLA antibodies are present and the survival of donor granulocytes is low by DHR analysis, transfusions should be discontinued, avoiding a therapy associated with high risk and unclear benefit.
Authors:
K F Heim; T A Fleisher; D F Stroncek; S M Holland; J I Gallin; H L Malech; S F Leitman
Related Documents :
8505276 - Diagnosis and treatment of atraumatic vascular insufficiency of the upper extremity: fe...
6605496 - Ocular counterrolling as an indicator of vestibular otolith function.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2010-12-22
Journal Detail:
Title:  Transfusion     Volume:  51     ISSN:  1537-2995     ISO Abbreviation:  Transfusion     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-10     Completed Date:  2011-08-23     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1154-62     Citation Subset:  IM    
Copyright Information:
© 2010 American Association of Blood Banks.
Affiliation:
Department of Transfusion Medicine and Laboratory Medicine, Warren Grant Magnuson Clinical Center and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1184, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Child, Preschool
Female
Flow Cytometry
Granulocytes / transplantation*
Granulomatous Disease, Chronic / therapy*
Humans
Leukocyte Transfusion / methods*
Male
Neutrophils / cytology
Young Adult
Grant Support
ID/Acronym/Agency:
ZIA CL002124-01/CL/CLC NIH HHS
Comments/Corrections
Comment In:
Transfusion. 2011 Jun;51(6):1128-31   [PMID:  21658032 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lack of effect of unrefrigerated young whole blood transfusion on patient outcomes after massive tra...
Next Document:  Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a comme...